Great frist results from $CRISPR Therapeutics AG(CRSP)$& $Vertex(VTNR)$study on gen editing therapy to cure Thalssemia.
CRSP is a clear win for 5y+ investors and has a massive growth ahead for the next 10 years, as a Biologist I can't but agree on the 9X figures.
“This approach uses CRISPR/Cas9 gene editing to enable the patient’s own cells to produce fetal hemoglobin, and to see results that demonstrate the potential for a treatment that may transform the lives of many patients is an exciting time for me and the team.”
https://www.businesswire.com/news/home/20210611005069/en/Vertex-and-CRISPR-Therapeutics-Present-New-Data-in-22-Patients-With-Greater-Than-3-Months-Follow-Up-Post-Treatment-With-Investigational-CRISPRCas9-Gene-Editing-Therapy-CTX001%E2%84%A2-at-European-Hematology-Association-Annual-Meeting
Comments